Literature DB >> 26178959

Cancer: A dendritic-cell brake on antitumour immunity.

Miriam Merad1, Hélène Salmon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26178959      PMCID： PMC4693607          DOI： 10.1038/523294a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Authors:  Stefani Spranger; Riyue Bao; Thomas F Gajewski
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

Review 2.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

3.  The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells.

Authors:  Fabiola Osorio; Simon J Tavernier; Eik Hoffmann; Yvan Saeys; Liesbet Martens; Jessica Vetters; Iris Delrue; Riet De Rycke; Eef Parthoens; Philippe Pouliot; Takao Iwawaki; Sophie Janssens; Bart N Lambrecht
Journal:  Nat Immunol       Date:  2014-01-19       Impact factor: 25.606

4.  Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Authors:  Lyse A Norian; Paulo C Rodriguez; Leigh A O'Mara; Jovanny Zabaleta; Augusto C Ochoa; Marina Cella; Paul M Allen
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

5.  Lipid accumulation and dendritic cell dysfunction in cancer.

Authors:  Donna L Herber; Wei Cao; Yulia Nefedova; Sergey V Novitskiy; Srinivas Nagaraj; Vladimir A Tyurin; Alex Corzo; Hyun-Il Cho; Esteban Celis; Brianna Lennox; Stella C Knight; Tapan Padhya; Thomas V McCaffrey; Judith C McCaffrey; Scott Antonia; Mayer Fishman; Robert L Ferris; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2010-07-11       Impact factor: 53.440

Review 6.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

Review 7.  The Janus face of dendritic cells in cancer.

Authors:  N Chaput; R Conforti; S Viaud; A Spatz; L Zitvogel
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

8.  ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.

Authors:  Juan R Cubillos-Ruiz; Pedro C Silberman; Melanie R Rutkowski; Sahil Chopra; Alfredo Perales-Puchalt; Minkyung Song; Sheng Zhang; Sarah E Bettigole; Divya Gupta; Kevin Holcomb; Lora H Ellenson; Thomas Caputo; Ann-Hwee Lee; Jose R Conejo-Garcia; Laurie H Glimcher
Journal:  Cell       Date:  2015-06-11       Impact factor: 41.582

9.  XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.

Authors:  Dimitrios Iliopoulos; Qing Zhang; Qianzi Tang; Xi Chen; Matthew B Greenblatt; Maria Hatziapostolou; Elgene Lim; Wai Leong Tam; Min Ni; Yiwen Chen; Junhua Mai; Haifa Shen; Dorothy Z Hu; Stanley Adoro; Bella Hu; Minkyung Song; Chen Tan; Melissa D Landis; Mauro Ferrari; Sandra J Shin; Myles Brown; Jenny C Chang; X Shirley Liu; Laurie H Glimcher
Journal:  Nature       Date:  2014-03-23       Impact factor: 49.962

10.  The transcription factor XBP-1 is essential for the development and survival of dendritic cells.

Authors:  Neal N Iwakoshi; Marc Pypaert; Laurie H Glimcher
Journal:  J Exp Med       Date:  2007-09-17       Impact factor: 14.307
View more
  7 in total

Review 1.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.

Authors:  Fang Wei; Dan Wang; Junyuan Wei; Niwen Tang; Le Tang; Fang Xiong; Can Guo; Ming Zhou; Xiaoling Li; Guiyuan Li; Wei Xiong; Shanshan Zhang; Zhaoyang Zeng
Journal:  Cell Mol Life Sci       Date:  2020-07-11       Impact factor: 9.261

2.  Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria.

Authors:  Wenguang Wang; Haiheng Xu; Qingsong Ye; Feng Tao; Ian Wheeldon; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Nat Biomed Eng       Date:  2022-01-20       Impact factor: 29.234

Review 3.  The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer.

Authors:  Yue Pan; Yucheng Fu; Yue Zeng; Xiaohan Liu; Yurong Peng; Chunhong Hu; Chao Deng; Zhenhua Qiu; Jian Zou; Yuxuan Liu; Fang Wu
Journal:  Biomark Res       Date:  2022-03-07

Review 4.  Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.

Authors:  Hamid Aria; Marzieh Rezaei; Shima Nazem; Abdolreza Daraei; Ghasem Nikfar; Behnam Mansoori; Maryam Bahmanyar; Alireza Tavassoli; Mohammad Kazem Vakil; Yaser Mansoori
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

5.  Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model.

Authors:  Shengbin Shi; Quan Rao; Chuangnian Zhang; Xiuyuan Zhang; Yibo Qin; Zuoxing Niu
Journal:  Transl Oncol       Date:  2018-01-28       Impact factor: 4.243

Review 6.  Dendritic cell biology and its role in tumor immunotherapy.

Authors:  Yingying Wang; Ying Xiang; Victoria W Xin; Xian-Wang Wang; Xiao-Chun Peng; Xiao-Qin Liu; Dong Wang; Na Li; Jun-Ting Cheng; Yan-Ning Lyv; Shu-Zhong Cui; Zhaowu Ma; Qing Zhang; Hong-Wu Xin
Journal:  J Hematol Oncol       Date:  2020-08-03       Impact factor: 17.388

7.  Huaier Extractum Promotes Dendritic Cells Maturation and Favors them to Induce Th1 Immune Response: One of the Mechanisms Underlying Its Anti-Tumor Activity.

Authors:  Jun Pan; Zhou Jiang; Dang Wu; Chenghui Yang; Zhen Wang; Jian Huang
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.